{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:43:04Z","timestamp":1759693384172,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.mehy.2019.109287","type":"journal-article","created":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T01:51:28Z","timestamp":1561341088000},"page":"109287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A potential role of toll-like receptors, IFN-\u03b3 and the phosphatidylinositol 3-kinase pathway in the pathogenesis of acquired mediastinal lymphatic malformation"],"prefix":"10.1016","volume":"131","author":[{"given":"Pradeep","family":"Goyal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonali","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priti","family":"Soin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Mattana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2019.109287_b0005","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3389\/fimmu.2013.00437","article-title":"Granuloma formation in pulmonary sarcoidosis","volume":"4","author":"Broos","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.mehy.2019.109287_b0010","first-page":"149","article-title":"ATS\/ERS\/WASOG statement on sarcoidosis. American Thoracic Society\/European Respiratory Society\/World Association of Sarcoidosis and other Granulomatous Disorders","volume":"16","author":"Hunninghake","year":"1999","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.mehy.2019.109287_b0015","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.clim.2011.03.015","article-title":"Regulatory T cells with reduced repressor capacities are extensively amplified in pulmonary sarcoid lesions and sustain granuloma formation","volume":"140","author":"Rappl","year":"2011","journal-title":"Clin Immunol"},{"key":"10.1016\/j.mehy.2019.109287_b0020","first-page":"283","article-title":"Thoracic lymphangioma in adults: CT and MR imaging features","volume":"162","author":"Shaffer","year":"1994","journal-title":"Am J Radiol"},{"key":"10.1016\/j.mehy.2019.109287_b0025","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.mehy.2019.109287_b0030","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/imr.12381","article-title":"Negative regulation of TLR signaling in myeloid cells-Implications for autoimmune diseases","volume":"269","author":"Hamerman","year":"2016","journal-title":"Immunol Rev"},{"key":"10.1016\/j.mehy.2019.109287_b0035","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/202816","article-title":"IFN-\u03b3 priming effects on the maintenance of effector memory CD4 (+) T cells and on phagocyte function: evidences from infectious diseases","volume":"2015","author":"Borges da Silva","year":"2015","journal-title":"J Immunol Res"},{"key":"10.1016\/j.mehy.2019.109287_b0040","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.4049\/jimmunol.1302379","article-title":"IFN-\u03b3 primes macrophage activation by increasing phosphatase and tensin homolog via downregulation of miR-3473b","volume":"193","author":"Wu","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2019.109287_b0045","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1084\/jem.166.5.1229","article-title":"Mosmann TR. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies","volume":"166","author":"Cherwinski","year":"1987","journal-title":"J Exp Med"},{"key":"10.1016\/j.mehy.2019.109287_b0050","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1189\/jlb.0612293","article-title":"The dual roles of inflammatory cytokines and chemokines in the regulation of autoimmune diseases and their clinical implications","volume":"93","author":"Shachar","year":"2013","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.mehy.2019.109287_b0055","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1513\/AnnalsATS.201209-078OC","article-title":"Heterogeneous characteristics of lymphatic microvasculatures associated with pulmonary sarcoid granulomas","volume":"10","author":"Yamashita","year":"2013","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.mehy.2019.109287_b0060","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1172\/JCI71611","article-title":"Lymphatic vessels and tertiary lymphoid organs","volume":"124","author":"Ruddle","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mehy.2019.109287_b0065","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.1182\/blood-2008-09-176776","article-title":"Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution","volume":"113","author":"Kataru","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.mehy.2019.109287_b0070","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.0105-2896.2004.00206.x","article-title":"Lymphotoxin and LIGHT signaling pathways and target genes","volume":"202","author":"Schneider","year":"2004","journal-title":"Immunol Rev"},{"key":"10.1016\/j.mehy.2019.109287_b0075","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3389\/fimmu.2016.00491","article-title":"High endothelial venules and lymphatic vessels in tertiary lymphoid organs: characteristics, functions, and regulation","volume":"7","author":"Ruddle","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.mehy.2019.109287_b0080","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.4049\/jimmunol.180.5.3467","article-title":"Lymphotoxin-\u03b11\u03b22 and LIGHT induce classical and noncanonical NF-\u03baB-dependent proinflammatory gene expression in vascular endothelial cells","volume":"180","author":"Madge","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2019.109287_b0085","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/jmg.2004.024802","article-title":"Milroy disease and the VEGFR-3 mutation phenotype","volume":"42","author":"Brice","year":"2005","journal-title":"J Med Genet"},{"key":"10.1016\/j.mehy.2019.109287_b0090","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jpeds.2014.12.069","article-title":"Lymphatic and other vascular malformative\/overgrowth disorders are caused by somatic mutations in PIK3CA","volume":"166","author":"Luks","year":"2015","journal-title":"J Pediatr"},{"key":"10.1016\/j.mehy.2019.109287_b0095","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.4161\/cc.8.9.8255","article-title":"PIK3CA mutations in human solid tumors: role in sensitivity to various therapeutic approaches","volume":"8","author":"Ligresti","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.mehy.2019.109287_b0100","doi-asserted-by":"crossref","first-page":"13375","DOI":"10.1074\/jbc.273.22.13375","article-title":"The tumor suppressor, PTEN\/ MMAC1 dephosphorylates the lipid second messenger, phosphatidylinositol 345-trisphosphate","volume":"273","author":"Maehama","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2019.109287_b0105","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3389\/fimmu.2012.00244","article-title":"Does the PI3K pathway promote or antagonize regulatory T cell development and function?","volume":"3","author":"Soond","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.mehy.2019.109287_b0110","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2217\/imt.14.103","article-title":"Targeting CD4+ T cells for the treatment of sarcoidosis: a promising strategy?","volume":"7","author":"Celada","year":"2015","journal-title":"Immunotherapy"},{"key":"10.1016\/j.mehy.2019.109287_b0115","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12948-015-0025-9","article-title":"Rituximab in refractory sarcoidosis: a single centre experience","volume":"13","author":"Cinetto","year":"2015","journal-title":"Clin Mol Allergy"},{"key":"10.1016\/j.mehy.2019.109287_b0120","first-page":"52","article-title":"Anti-interferon-gamma antibodies in the treatment of autoimmune diseases","volume":"5","author":"Skurkovich","year":"2003","journal-title":"Curr Opin Mol Ther"},{"key":"10.1016\/j.mehy.2019.109287_b0125","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3257","article-title":"Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies","volume":"137","author":"Adams","year":"2016","journal-title":"Pediatrics"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987719305961?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987719305961?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:14:59Z","timestamp":1759691699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987719305961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":25,"alternative-id":["S0306987719305961"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2019.109287","relation":{},"ISSN":["0306-9877"],"issn-type":[{"type":"print","value":"0306-9877"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A potential role of toll-like receptors, IFN-\u03b3 and the phosphatidylinositol 3-kinase pathway in the pathogenesis of acquired mediastinal lymphatic malformation","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2019.109287","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109287"}}